MGMT and glioblastoma: Results from a second model with fewer assumptions yielded similar results (Figures S3-S6), as did a version of the model with a Michaelis-Menten term added (Figures S7-S9), suggesting that 100 μM TMZ dosing as daily MGMT protein abundance begins to decrease may provide maximal efficacy against GBM growth.